Zhigong Wei, Huijiao Chen, Fei Chen, Jun Liu, Xingchen Peng. "Neoadjuvant chemoimmunotherapy with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-2): An open-label, single-arm, phase 2 study.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.6069